New Delhi – Despite a blistering 19% rally in the Nifty Midcap 100 index over the last six months, market analysts are flagging several key stocks that they believe still have significant room to run. Consensus data shows at least six mid-cap companies currently holding “Strong Buy” or “Buy” ratings, with analysts projecting potential upsides of 26% to 30% from their current levels.
The strong market performance has led to a more selective approach from experts, but conviction remains high for specific companies across various sectors, including healthcare, hospitality, and manufacturing.
Leading the high-conviction list is Polycab India. A strong consensus of 34 analysts has issued a “Strong Buy” rating for the stock, anticipating a potential 30% upside with a target price of Rs 7,723.
Following closely is Indian Hotels Company Ltd. The hospitality giant boasts a “Strong Buy” rating from 28 analysts, who have set a consensus target price of Rs 708, implying a 28% potential gain from its current trading level.
Analysts also see significant value in the real estate and energy sectors. Prestige Estates Projects holds a “Strong Buy” rating from 19 analysts, targeting a 27% upside at Rs 1,986. Similarly, state-run Oil India is in favor, with 18 analysts assigning it a “Strong Buy” and projecting a 27% gain to Rs 788.
The healthcare sector features two prominent names. Global Health Ltd, which operates the Medanta hospital chain, has garnered a “Strong Buy” rating from 19 analysts, who see a 26% potential upside to a target of Rs 1,608.
Finally, pharma major Lupin Ltd holds a “Buy” consensus from a broad group of 32 analysts. The collective target price for the stock is Rs 1,857, representing a potential upside of 26%.
Disclaimer: This article is for informational purposes only and should not be considered investment advice. Capital Mirror is not responsible for any investment decisions taken based on the information provided.
